Oral Contraceptives Have Strong Rx-To-OTC Consumer Support - Survey
This article was originally published in The Tan Sheet
Executive Summary
Switching oral contraceptives for women from Rx-to-OTC status was viewed as a "good idea" by a majority of respondents to a recent survey conducted by the Guideline Research Group (New York).
You may also be interested in...
Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA
FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.
Mevacor Study Comparing Rx, OTC Use Is Among FDA Panel Suggestions
Merck should conduct a head-to-head comparison study of Mevacor use in prescription and over-the-counter settings, Endocrinologic & Metabolic Drugs Advisory Committee member William Tamborlane, MD, said during a review of Merck's OTC switch application for lovastatin 10 mg.
OTC Emergency Contraceptive Restricted Access Supported By Gynetics Exec
Age requirements and other restrictions would allow emergency contraceptives (ECs) to be safely sold OTC, Gynetics Chief Financial and Operating Officer Jack Stover stated at an FDA public meeting June 29.